Tag archive for ‘Europe’
Infosys selected by ArcelorMittal as digital transformation partner
By businessnewstoday On Friday, April 9th, 2021
0 Comments

Infosys selected by ArcelorMittal as digital transformation partner

(adsbygoogle = window.adsbygoogle || []).push({}); Infosys said that steel production company ArcelorMittal has selected the company to help expedite its digital transformation journey. The partnership More...

Gan & Lee gets EMA orphan drug status for GLR2007 in glioma
By businessnewstoday On Tuesday, April 6th, 2021
0 Comments

Gan & Lee gets EMA orphan drug status for GLR2007 in glioma

Gan & Lee Pharmaceuticals has been granted orphan drug designation for GLR2007 from the European Medicine Agency (EMA) for the treatment of glioma, a type of tumor found in the brain and spinal cord. The Chinese More...

Bioniz Therapeutics gets EC orphan drug status for BNZ-1 for cutaneous T-cell lymphoma.
By businessnewstoday On Tuesday, April 6th, 2021
0 Comments

Bioniz Therapeutics gets EC orphan drug status for BNZ-1 for CTCL

Bioniz Therapeutics has secured orphan drug designation for BNZ-1 from the European Commission (EC) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare type of skin cancer. Previously, BNZ-1 was given More...

Önusberget wind farm : GE Renewable Energy to supply 137 Cypress 5.5 MW turbines.
By Soujanya Ravi On Saturday, March 6th, 2021
0 Comments

Önusberget wind farm : GE Renewable Energy bags contract for 137 turbines

GE Renewable Energy has signed an agreement with Luxcara, an asset management company, to deliver turbines for the latter’s 753MW Önusberget wind farm in Sweden. As per the agreement signed in February, GE Renewable More...

By pharmanewsdaily On Sunday, November 29th, 2020
0 Comments

Sedana Medical seeks approval for inhaled sedation candidate Sedaconda

Sedana Medical has submitted an application seeking approval for its drug candidate Sedaconda (isoflurane), previously called IsoConDa, for inhaled sedation in intensive care. The application has been filed with More...

By pharmanewsdaily On Tuesday, November 24th, 2020
0 Comments

BMS gets Opdivo EC approval for second-line treatment of ESCC

Opdivo EC approval : Bristol Myers Squibb (BMS) has secured approval from the European Commission (EC) for its immunotherapy Opdivo (nivolumab) as a second-line treatment for unresectable advanced, recurrent or More...

By pharmanewsdaily On Wednesday, September 9th, 2020
0 Comments

Takeda to sell select non-core assets to Cheplapharm for $562m

Takeda Pharmaceutical has agreed to sell a portfolio of certain non-core prescription pharma products sold mainly in Europe and Canada to German pharma company Cheplapharm for about $562 million. The portfolio to More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Wednesday, July 1st, 2020
0 Comments

Noxopharm launches NOXCOVID-1 clinical trial of Veyonda across Europe

Noxopharm, an Australian clinical-stage pharma company, has started the phase 1 NOXCOVID-1 clinical trial for Veyonda in Europe to evaluate the anti-cancer drug candidate as a potential treatment for cytokine storm More...

By pharmanewsdaily On Sunday, July 21st, 2019
0 Comments

Sanofi, Regeneron secure Libtayo EMA approval for a type of skin cancer

Libtayo EMA approval : The European Commission has given conditional approval for Libtayo (cemiplimab) for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC), More...

By pharmanewsdaily On Sunday, July 14th, 2019
0 Comments

ViiV Healthcare secures Dovato EMA approval for HIV-1 treatment

Dovato EMA approval : The European Commission (EC) has approved ViiV Healthcare’s once-daily, single-pill, two-drug regimen Dovato (dolutegravir/lamivudine) for the treatment of human immunodeficiency virus type More...